Coagulation panel: PT/INR, aPTT, fibrinogen and D-dimer explained

A coagulation panel is a group of blood tests that check how well your blood forms a clot. The core panel usually reports prothrombin time (PT) with its standardized INR, and activated partial thromboplastin time (aPTT); fibrinogen and D-dimer are often added depending on why it was ordered. Platelet count is not part of this panel — it comes from a complete blood count, even though platelets work alongside these clotting factors to stop bleeding.

This article covers what each part measures, reference ranges as cited sources report them, why INR targets on warfarin are set individually, why DOACs are not tracked with these tests, what makes D-dimer useful and unreliable as proof of a clot, preparation, and red flags for prompt attention.

What the coagulation panel measures

Prothrombin (PT) and partial thromboplastin time (aPTT) both time how long a blood sample takes to clot, but they check different parts of the clotting process. Per Testing.com, PT measures the extrinsic and common coagulation pathways, while aPTT measures the intrinsic and common pathways; running both together gives a fuller picture of where a clotting problem may originate. Because different labs use different reagents for PT, MedlinePlus notes raw values can vary between labs — which is why PT is converted into the INR, a standardized ratio comparable across labs and methods.

• Prothrombin (PT) and INR — extrinsic and common pathways; used for unexplained bleeding or clotting, clotting ability before surgery, and, as the INR, warfarin monitoring.
• aPTT — intrinsic and common pathways; used for unexplained bleeding or clotting, and to monitor unfractionated heparin therapy.
• Fibrinogen — a clotting factor made by the liver; measured as a level (usually mg/dL) or as how well it functions in forming a clot.
• D-dimer — a fragment left over when a clot breaks down; helps rule out a clot such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
• Thrombin time — offered by some labs as an add-on; per Testing.com, most often prolonged by heparin contamination or a direct thrombin inhibitor such as dabigatran, and can also point to a low or dysfunctional fibrinogen level.

Platelets, which work alongside these factors to stop bleeding, are reported on a complete blood count rather than here. For the wider set of tests used to assess cardiovascular risk, see our heart health blood tests guide.

Reference ranges

Testing.com is explicit that these are “typical reference ranges (approximate; varies by lab)” — use your own lab’s printed reference interval rather than a number from this table, especially for aPTT, which varies by lab more than most coagulation markers.

INR on warfarin: a target your clinician sets, not a fixed number

If you take warfarin, your INR result is compared against a target range set for your specific condition by the clinician managing your treatment — not against a single number that applies to everyone. Testing.com cites the Mayo Clinic’s typical range of 2.0 to 3.0 as generally effective for people on warfarin for conditions such as atrial fibrillation or a blood clot in the leg or lung, and notes that certain mechanical heart valves may need a different, higher target. That 2.0–3.0 figure is the source’s description of a typical target, not a number to apply to your own result — your actual target, and any change to your dose, is set by the person managing your care.

DOACs are not monitored with this panel

Direct oral anticoagulants (DOACs) — apixaban and rivaroxaban among them — work differently from warfarin, and Testing.com states plainly that they “work differently and don’t need INR monitoring,” adding that “if you’re on a DOAC, this test isn’t typically used to track your medication.” That means a normal or abnormal INR or aPTT in someone taking a DOAC should not be read as information about how that medicine is working — routine coagulation testing is not built to answer that question for DOACs the way it is for warfarin. Questions about DOAC dosing or monitoring belong with the prescribing clinician.

Fibrinogen and the citrate-filled tube

Fibrinogen is usually reported in milligrams per deciliter (mg/dL); the American Board of Internal Medicine’s range, cited by Testing.com, is 200–400 mg/dL, converting to 2.0–4.0 g/L. Testing.com adds that reference ranges “can vary depending on the procedures and equipment in each laboratory.”

The coagulation panel is drawn into a citrate tube, which Testing.com describes as the standard tube for coagulation tests.

D-dimer: sensitive, not specific

D-dimer is useful mainly for what a low result rules out, not for what a high result proves. MedlinePlus states that if your D-dimer is low or normal, “it means you probably don’t have a clotting disorder,” while a result above the normal range “may be a sign of a clotting disorder” but is not diagnostic on its own — additional tests are needed “to show where the blood clot is located or what type of clotting disorder you have.” Testing.com frames the trade-off directly: D-dimer “is a sensitive test but has a poor specificity,” so it should help rule a clot out rather than confirm one.

D-dimer rises for reasons that have nothing to do with a dangerous clot. MedlinePlus lists pregnancy, heart disease, rheumatoid arthritis and recent surgery among causes of a high D-dimer, and notes that being older or immobilized can also raise it; Testing.com separately lists recent surgery, trauma, infection, heart attack and some cancers — fibrin forms and breaks down in all of these, not only when a dangerous clot is present. A single elevated D-dimer is read alongside symptoms and other tests rather than treated as proof of a clot; interpreting a result in pregnancy is a question for the clinician managing that pregnancy — see our pregnancy blood tests guide.

Blood thinners can also work against the test in the opposite direction: MedlinePlus states that treatment with blood thinner medicines “may cause a false negative D-dimer test,” meaning the result can look normal even though a clotting disorder is present. Tell whoever orders the test if you are on an anticoagulant.

When the panel is ordered

Testing.com and MedlinePlus describe similar reasons for ordering these tests: before surgery or another bleeding-risk procedure, to investigate unexplained bleeding or bruising, to monitor warfarin dosing, when liver disease is present or suspected, during pregnancy if a clotting disorder or DIC is suspected, and when a clot such as DVT or PE is suspected. A clinician orders the specific combination based on the question being asked, not as a fixed package. Genetic clotting-tendency screening, such as factor V Leiden, is ordered by a clinician in selected cases and is a separate topic from the panel here.

Preparation and what can distort a result

No fasting is required — Testing.com states this explicitly for the PT/INR and PT/INR/aPTT panels, and notes you can eat and drink normally beforehand. What matters more is telling your provider about every medication and supplement: Testing.com notes antibiotics can raise PT while barbiturates, oral contraceptives and vitamin K supplements can lower it, and that aspirin, heparin, antihistamines, vitamin C and herbal supplements such as St. John’s Wort, fish oil and ginkgo can also affect results. If you take warfarin, Testing.com notes, citing MedlinePlus, that sudden large changes in vitamin K intake can shift your INR, which is why consistent intake is usually advised. If you take heparin, tell the person ordering the test — heparin contamination is, per Testing.com, one of the most common causes of an unexpectedly prolonged thrombin time. Sample quality also matters: the tube needs to be filled to its mark, since the ratio of citrate to blood is part of what the result depends on.

Red flags — when to seek help

Bleeding that will not stop after ordinary pressure, black or tarry stools, and vomiting or coughing up blood are commonly listed among possible signs of bleeding on anticoagulant treatment, and any of these calls for contacting your clinic or emergency services rather than waiting. If you take warfarin and a routine INR comes back far above your target range, contact your clinic promptly rather than waiting for the next scheduled test — that is exactly what regular monitoring is designed to catch early. Symptoms of a possible clot — leg pain or swelling, chest pain, sudden shortness of breath — need urgent care regardless of a previous coagulation result.

Tracking coagulation results with HealthLab

For someone on warfarin, a single INR matters less than how it moves relative to the clinic’s target range. HealthLab can import a lab report from a PDF or photo using AI recognition, or a result can be entered manually with the clinic’s own target range and unit — manual entry is free and unlimited, and one import is free, unlimited import is Pro. Each biomarker, including INR, gets its own trend chart, results export to PDF for an appointment, and additional profiles for family members come with Pro.

See the labs page for the full list of what HealthLab tracks. HealthLab organizes results and helps you prepare for the conversation with your clinic; it does not diagnose a condition, set an INR target, or decide whether a dose should change.

Frequently asked questions